JPS5251014A - Improvement of organic compound - Google Patents
Improvement of organic compoundInfo
- Publication number
- JPS5251014A JPS5251014A JP51123463A JP12346376A JPS5251014A JP S5251014 A JPS5251014 A JP S5251014A JP 51123463 A JP51123463 A JP 51123463A JP 12346376 A JP12346376 A JP 12346376A JP S5251014 A JPS5251014 A JP S5251014A
- Authority
- JP
- Japan
- Prior art keywords
- improvement
- organic compound
- organic
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2546577A DE2546577B2 (de) | 1975-10-17 | 1975-10-17 | Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5251014A true JPS5251014A (en) | 1977-04-23 |
JPS5854122B2 JPS5854122B2 (ja) | 1983-12-02 |
Family
ID=5959411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51123463A Expired JPS5854122B2 (ja) | 1975-10-17 | 1976-10-16 | 新規なエルゴットアルカロイド薬剤およびその製法 |
Country Status (28)
Country | Link |
---|---|
JP (1) | JPS5854122B2 (ja) |
AT (1) | AT362510B (ja) |
AU (1) | AU508628B2 (ja) |
BE (1) | BE847368A (ja) |
CA (1) | CA1079641A (ja) |
CH (1) | CH643737A5 (ja) |
CS (1) | CS199647B2 (ja) |
DE (1) | DE2546577B2 (ja) |
DK (1) | DK146194C (ja) |
ES (1) | ES452420A1 (ja) |
FI (1) | FI762875A (ja) |
FR (1) | FR2327764A1 (ja) |
GB (1) | GB1560406A (ja) |
GR (1) | GR61268B (ja) |
HK (1) | HK3183A (ja) |
HU (1) | HU172533B (ja) |
IE (1) | IE43778B1 (ja) |
IL (1) | IL50686A (ja) |
MY (1) | MY8400063A (ja) |
NL (1) | NL184558C (ja) |
NO (1) | NO144468C (ja) |
NZ (1) | NZ182341A (ja) |
PH (1) | PH14513A (ja) |
PT (1) | PT65719B (ja) |
SE (1) | SE430379B (ja) |
SG (1) | SG63082G (ja) |
SU (1) | SU1165223A3 (ja) |
ZA (1) | ZA766166B (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS584716A (ja) * | 1981-06-24 | 1983-01-11 | サンド・アクチエンゲゼルシャフト | 医薬用製剤 |
JPH08253418A (ja) * | 1983-12-09 | 1996-10-01 | Euro Celtique Sa | 高血圧症の治療、抗高血圧及び利尿のためのチアジド化合物及び組成物 |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1572226A (en) * | 1977-11-03 | 1980-07-30 | Hoechst Uk Ltd | Pharmaceutical preparations in solid unit dosage form |
US4411882A (en) | 1978-12-21 | 1983-10-25 | Sandoz Ltd. | Galenical compositions |
DK154607C (da) * | 1978-12-21 | 1989-06-05 | Sandoz Ag | Fremgangsmaade til fremstilling af en laegemiddelform til oral administration af ergotalkaloider |
FR2454804B1 (fr) * | 1979-04-26 | 1986-11-21 | Sanofi Sa | Medicament a base de dihydroergotoxine et son procede de preparation |
NL194389C (nl) * | 1984-06-14 | 2002-03-04 | Novartis Ag | Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager. |
ES2039287T3 (es) * | 1987-01-14 | 1993-09-16 | Ciba-Geigy Ag | Procedimiento para la obtencion de un sistema terapeutico peroral para productos activos dificilmente solubles. |
FR2610827B1 (fr) * | 1987-02-18 | 1991-09-13 | Pf Medicament | Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication |
US5064656A (en) * | 1989-11-14 | 1991-11-12 | Dr. Gergely & Co. | Uncoated pharmaceutical reaction tablet |
DE4401646A1 (de) * | 1994-01-21 | 1995-07-27 | Krewel Werke Gmbh | Optimal freisetzende Kava-Extrakte |
US6524832B1 (en) | 1994-02-04 | 2003-02-25 | Arch Development Corporation | DNA damaging agents in combination with tyrosine kinase inhibitors |
EP1039908B1 (en) * | 1997-12-22 | 2004-02-25 | Schering Corporation | Molecular dispersion composition with enhanced bioavailability |
US6632455B2 (en) | 1997-12-22 | 2003-10-14 | Schering Corporation | Molecular dispersion composition with enhanced bioavailability |
US6316462B1 (en) | 1999-04-09 | 2001-11-13 | Schering Corporation | Methods of inducing cancer cell death and tumor regression |
AU2165301A (en) * | 1999-12-03 | 2001-06-12 | Polichem S.A. | Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
US7771746B2 (en) | 1999-12-03 | 2010-08-10 | Polichem Sa | Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
US7135436B2 (en) | 2003-05-05 | 2006-11-14 | J.F. Daley International, Ltd. | Solid algicide, preparation and usage in recirculating water |
US20060141038A1 (en) * | 2003-06-27 | 2006-06-29 | Bioprogress S. P. A. | Composite product obtainable by cogrinding of a active principle with a copolymer n-vinyl-2 pyrrolidone/vinyl-acetate |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1175430A (en) * | 1966-04-07 | 1969-12-23 | Sandoz Ltd | Pharmaceutical Compositions containing Ergot Alkaloids |
-
1975
- 1975-10-17 DE DE2546577A patent/DE2546577B2/de not_active Withdrawn
-
1976
- 1976-10-01 CH CH1244876A patent/CH643737A5/de not_active IP Right Cessation
- 1976-10-08 DK DK454176A patent/DK146194C/da not_active IP Right Cessation
- 1976-10-08 NO NO763446A patent/NO144468C/no unknown
- 1976-10-08 FI FI762875A patent/FI762875A/fi not_active Application Discontinuation
- 1976-10-08 SE SE7611189A patent/SE430379B/xx not_active IP Right Cessation
- 1976-10-13 NL NLAANVRAGE7611295,A patent/NL184558C/xx not_active IP Right Cessation
- 1976-10-14 CA CA263,423A patent/CA1079641A/en not_active Expired
- 1976-10-14 FR FR7630866A patent/FR2327764A1/fr active Granted
- 1976-10-14 PH PH19008A patent/PH14513A/en unknown
- 1976-10-15 BE BE171578A patent/BE847368A/xx not_active IP Right Cessation
- 1976-10-15 AT AT767976A patent/AT362510B/de not_active IP Right Cessation
- 1976-10-15 GB GB42907/76A patent/GB1560406A/en not_active Expired
- 1976-10-15 IL IL50686A patent/IL50686A/xx unknown
- 1976-10-15 IE IE2282/76A patent/IE43778B1/en not_active IP Right Cessation
- 1976-10-15 CS CS766685A patent/CS199647B2/cs unknown
- 1976-10-15 ZA ZA00766166A patent/ZA766166B/xx unknown
- 1976-10-15 AU AU18754/76A patent/AU508628B2/en not_active Expired
- 1976-10-15 ES ES452420A patent/ES452420A1/es not_active Expired
- 1976-10-15 NZ NZ182341A patent/NZ182341A/xx unknown
- 1976-10-15 HU HU76SA00002985A patent/HU172533B/hu not_active IP Right Cessation
- 1976-10-15 PT PT65719A patent/PT65719B/pt unknown
- 1976-10-15 SU SU762412401A patent/SU1165223A3/ru active
- 1976-10-16 JP JP51123463A patent/JPS5854122B2/ja not_active Expired
- 1976-10-16 GR GR51952A patent/GR61268B/el unknown
-
1982
- 1982-12-23 SG SG630/82A patent/SG63082G/en unknown
-
1983
- 1983-01-20 HK HK31/83A patent/HK3183A/xx unknown
-
1984
- 1984-12-30 MY MY63/84A patent/MY8400063A/xx unknown
Non-Patent Citations (2)
Title |
---|
JOURNAL PHARM ACEUTICAL SCIENCE=1966 * |
THE MERCK TRDEX * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS584716A (ja) * | 1981-06-24 | 1983-01-11 | サンド・アクチエンゲゼルシャフト | 医薬用製剤 |
JPH0255405B2 (ja) * | 1981-06-24 | 1990-11-27 | Sandoz Ag | |
JPH08253418A (ja) * | 1983-12-09 | 1996-10-01 | Euro Celtique Sa | 高血圧症の治療、抗高血圧及び利尿のためのチアジド化合物及び組成物 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5366440A (en) | Improvement of organic compound | |
JPS5259180A (en) | Improving concerning organic compound | |
GB1539006A (en) | Aminoalkylammonium compound | |
ZA763611B (en) | Organic compounds | |
JPS5251014A (en) | Improvement of organic compound | |
JPS51113900A (en) | Riphamycin compound | |
JPS5273891A (en) | Novel cephalospoline compound | |
JPS51115467A (en) | Improvement of organic compound | |
JPS5295631A (en) | Improvement of organic compound | |
JPS51136694A (en) | Novel antiibacterial compound | |
JPS51125391A (en) | Improvement rerating to organic compounds | |
JPS5223076A (en) | Antiiinflammatory compound | |
JPS5223073A (en) | Improvement of organic compound | |
JPS5293766A (en) | Improvement of organic compound | |
JPS51143699A (en) | Riphamycin compound | |
JPS5236665A (en) | 44dithioo33imide azethizinee 22one compound | |
JPS51125060A (en) | Improvement of organic compound | |
JPS56142292A (en) | Novel compound | |
JPS5231062A (en) | Perfluoroalkylthionorbornane compound | |
JPS5268173A (en) | Improvement of organic compound | |
JPS5312839A (en) | Improvement of organic compound | |
JPS52261A (en) | Improvement of organic compound | |
JPS5273881A (en) | Improvement of organic compound | |
JPS5251398A (en) | Production of organic compound | |
JPS51125392A (en) | Improvement rerating to organic compounds |